Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase

被引:285
作者
Thoma, R [1 ]
Schulz-Gasch, T [1 ]
D'Arcy, B [1 ]
Benz, J [1 ]
Aebi, J [1 ]
Dehmlow, H [1 ]
Hennig, M [1 ]
Stihle, M [1 ]
Ruf, A [1 ]
机构
[1] Hoffmann La Roche Ag, Pharma Res Discovery Chem, CH-4070 Basel, Switzerland
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature02993
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In higher organisms the formation of the steroid scaffold is catalysed exclusively by the membrane-bound oxidosqualene cyclase (OSC; lanosterol synthase). In a highly selective cyclization reaction OSC forms lanosterol with seven chiral centres starting from the linear substrate 2,3-oxidosqualene. Valuable data on the mechanism of the complex cyclization cascade have been collected during the past 50 years using suicide inhibitors, mutagenesis studies and homology modelling. Nevertheless it is still not fully understood how the enzyme catalyses the reaction(1,2). Because of the decisive role of OSC in cholesterol biosynthesis it represents a target for the discovery of novel anticholesteraemic drugs that could complement the widely used statins(3). Here we present two crystal structures of the human membrane protein OSC: the target protein with an inhibitor that showed cholesterol lowering in vivo opens the way for the structure-based design of new OSC inhibitors. The complex with the reaction product lanosterol gives a clear picture of the way in which the enzyme achieves product specificity in this highly exothermic cyclization reaction.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 31 条
  • [1] Photoaffinity labeling of oxidosqualene cyclase and squalene cyclase by a benzophenone-containing inhibitor
    Abe, I
    Zheng, YF
    Prestwich, GD
    [J]. BIOCHEMISTRY, 1998, 37 (17) : 5779 - 5784
  • [2] INTRACELLULAR PROTEIN TOPOGENESIS
    BLOBEL, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (03): : 1496 - 1500
  • [3] Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: Optimization from lipid profiles
    Brown, GR
    Hollinshead, DM
    Stokes, ESE
    Clarke, DS
    Eakin, MA
    Foubister, AJ
    Glossop, SG
    Griffiths, D
    Johnson, MC
    McTaggart, F
    Mirrlees, DJ
    Smith, GJ
    Wood, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) : 1306 - 1311
  • [4] Molecular cloning of a Schizosaccharomyces pombe cDNA encoding lanosterol synthase and investigation of conserved tryptophan residues
    Corey, EJ
    Matsuda, SPT
    Baker, CH
    Ting, AY
    Cheng, HM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (02) : 327 - 331
  • [5] Methodology for the preparation of pure recombinant S-cerevisiae lanosterol synthase using a Baculovirus expression system. Evidence that oxirane cleavage and A-ring formation are concerted in the biosynthesis of lanosterol from 2,3-oxidosqualene
    Corey, EJ
    Cheng, HM
    Baker, CH
    Matsuda, SPT
    Li, D
    Song, XL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (06) : 1277 - 1288
  • [6] Studies on the substrate binding segments and catalytic action of lanosterol synthase. Affinity labeling with carbocations derived from mechanism-based analogs of 2,3-oxidosqualene and site-directed mutagenesis probes
    Corey, EJ
    Cheng, HM
    Baker, CH
    Matsuda, SPT
    Li, D
    Song, XL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (06) : 1289 - 1296
  • [7] Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors
    Dehmlow, H
    Aebi, JD
    Jolidon, S
    Ji, YH
    von der Mark, EM
    Himber, J
    Morand, OH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) : 3354 - 3370
  • [8] Cation-π interactions in structural biology
    Gallivan, JP
    Dougherty, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) : 9459 - 9464
  • [9] ON THE IMPORTANCE OF ORIENTATION IN GENERAL BASE CATALYSIS BY CARBOXYLATE
    GANDOUR, RD
    [J]. BIOORGANIC CHEMISTRY, 1981, 10 (02) : 169 - 176
  • [10] PEPTIDE MECHANICS - A FORCE-FIELD FOR PEPTIDES AND PROTEINS WORKING WITH ENTIRE RESIDUES AS SMALLEST UNITS
    GERBER, PR
    [J]. BIOPOLYMERS, 1992, 32 (08) : 1003 - 1017